PDE4 inhibition in the treatment of psoriasis: Advances from Celgene

摘要

Celgene Corporation is a global pharmaceutical company dedicated to the discovery, development and commercialisation of innovative therapies for the treatment of cancer and inflammatory diseases. Our research focuses on providing therapeutic options in diseases where there are unmet needs. Psoriatic disease is one such area where Celgene is committed to understanding and meeting patients' needs.